Pyrimidine compounds
US7220736B2 · kind B2 · utility
10Cited by
7References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2001 |
| Grant date | May 22, 2007 |
| Priority date | — |
| Expiry date | Aug 14, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65583
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A cyclic compound of the formula (I) or a pharmacologically acceptable salt thereof, The compound of the present invention has excellent selective PDE V inhibitory activity and therefore, is useful as a therapeutic or prophylactic drug for treating various diseases due to functional disorders on cGMP-signaling.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.